Recent Pharmaceuticals News

Engineer Project Manager Talks With Scientist working on Computer
Investing Articles

Up 173%, can Avacta shares continue this incredible run?  

In the last few months, Avacta shares have jumped significantly. But does this warrant an investment or is it just…

Read more »

A GlaxoSmithKline scientist uses a microscope
Investing Articles

Should I buy this FTSE 100 stock?

The GlaxoSmithKline share price has struggled over the past 12 months. Here, Charlie Keough looks at if this FTSE 100…

Read more »

Hand arranging wood block stacking as step stair on paper pink background
Investing Articles

The Open Orphan (ORPH) share price is surging. Should I buy now?

The Open Orphan (ORPH) share price has surged more than 600% in a year. Is it too late to buy?…

Read more »

Investing Articles

Have £2,000 to spend? These out-of-favour growth stocks could still help you retire early

Paul Summers takes a look at two acquisition-friendly growth stocks, both of which reported to the market this morning.

Read more »

Investing Articles

Why I’d stash banking stocks and pharma stocks in my 2018 ISA

Here's why the banking and pharmaceutical sectors could provide great long-term ISA investments.

Read more »

Investing Articles

Should you invest in banking or pharma stocks for retirement right now?

To me, there’s one clear winner in the banking-versus-pharma stocks debate.

Read more »

Investing Articles

This promising small-cap stock could be a millionaire maker in 2018

For those willing to take the risk, Paul Summers thinks there could be substantial upside ahead for backers of this…

Read more »

Investing Articles

Is GlaxoSmithKline plc still a strong buy after Q3 results?

Bilaal Mohamed shares his views on today's third-quarter results from GlaxoSmithKline plc (LON:GSK).

Read more »

Investing Articles

2 turnaround stocks that could make you rich

Bilaal Mohamed picks out two battered pharmaceutical stocks that could turn out to be excellent recovery plays.

Read more »

Investing Articles

Why GlaxoSmithKline plc is the only pharma stock I’d ever own

In a volatile industry, GlaxoSmithKline plc (LON: GSK) stands out for its reliable growth, high dividend and bargain valuation.

Read more »

Investing Articles

2 value stocks to consider in an expensive market: Indivior plc and Impellam Group plc

Should you buy Indivior plc (LON:INDV) and Impellam Group plc (LON:IPEL) as value plays following today's announcements?

Read more »

Investing Articles

This forgotten growth stock deserves more attention

Can this growth stock's "unusual" strategy help it to deliver attractive long-term returns?

Read more »

Investing Articles

Does cancer breakthrough make this stock a better buy than AstraZenenca plc?

Should investors ditch AstraZeneca plc (LON:AZN) in favour of this promising AIM-listed biotech firm?

Read more »

Investing Articles

2 safe FTSE 100 shares with dividend yields above 4%

Are these the best FTSE 100 shares for dividends and safety?

Read more »

Investing Articles

Is this small-cap value stock the next Shire plc?

Could this company become the next Shire plc (LON: SHP) or is it set to fail?

Read more »

Investing Articles

2 top healthcare shares for growth investors right now

Are these the best healthcare stocks to buy for 2017?

Read more »

Investing Articles

Better buy: GlaxoSmithKline plc vs Shire plc

Growth and income investors will both find something to cheer with GlaxoSmithKline plc (LON: GSK) and Shire plc (LON: SHP).

Read more »

Investing Articles

How GlaxoSmithKline plc’s first-mover advantage could power future profits

GlaxoSmithkline plc (LON: GSK) could be looking at its next blockbuster.

Read more »

Investing Articles

Can these Trump winners extend their gains?

Should you continue to buy these Trump winners?

Read more »

Investing Articles

Should you ditch these Footsie pharma stocks right now!

Are these blue chips now too dicey to hold?

Read more »

Investing Articles

Could these top-performing stocks be about to collapse?

Bilaal Mohamed considers whether these shares are heading for a correction after this year's spectacular gains.

Read more »

Investing Articles

2 firms to hold until you retire and beyond

Brexit looks like a sideshow for these enduring businesses.

Read more »

Investing Articles

Are these the FTSE 100’s hottest growth stocks?

Bilaal Mohamed reveals two shares from the FTSE 100 (INDEXFTSE:UKX) with plenty of upside potential.

Read more »

Investing Articles

Why Neil Woodford is unfazed by inflation and sterling’s plunge

The great investor sees plenty of opportunity ahead with shares.

Read more »

Investing Articles

2 firms to hold until you retire

Brexit looks like a sideshow for these businesses.

Read more »

Investing Articles

Is GlaxoSmithKline plc about to crash?

Today's update may be positive but should investors now consider moving on from FTSE 100 favourite GlaxoSmithKline plc (LON:GSK)?

Read more »

Investing Articles

2 growing FTSE 100 firms to consider now

Growth can be a compelling component of value as with these two FTSE 100 (INDEXFTSE: UKX) stalwarts.

Read more »

Investing Articles

Are these top healthcare stocks in your portfolio?

These two healthcare stocks are attractive on long-term fundamentals.

Read more »

Investing Articles

Is Dechra Pharmaceuticals plc a better buy than GlaxoSmithKline plc after today’s news?

Royston Wild weighs up the investment potential of drugs deities Dechra Pharmaceuticals plc (LON: DPH) and GlaxoSmithKline plc (LON: GSK).

Read more »

Investing Articles

How safe is GlaxoSmithKline plc’s dividend?

Are dividends built to endure at GlaxoSmithKline plc (LON: GSK), or is trouble ahead?

Read more »

Investing Articles

Simply the best growth stocks in the FTSE 100?

Bilaal Mohamed reveals three often-overlooked companies from the FTSE 100 (INDEXFTSE: UKX) with exciting growth potential.

Read more »

Investing Articles

Tech vs biotech: Is AstraZeneca plc or Apple Inc. the better buy?

Should you invest in biotech giant AstraZeneca plc (LON:AZN) or consumer king Apple Inc. (NASDAQ:AAPL)?

Read more »

Investing Articles

Should you buy GlaxoSmithKline plc after today’s results?

Will a return to growth make GlaxoSmithKline plc (LON: GSK) a screaming buy?

Read more »

Investing Articles

3 shares Neil Woodford backs despite Brexit ‘sideshow’

Britain's well-respected fund manager sees bigger problems for Britain than Brexit. This is what he holds to defend against them.

Read more »

Investing Articles

3 Brexit-resistant shares

These three companies look well placed to avoid Brexit fallout.

Read more »

Investing Articles

3 top pharma stocks immune to Brexit: AstraZeneca plc, Shire plc and Hikma Pharmaceuticals plc

Bilaal Mohamed looks at three pharmaceuticals plays that could offer shelter from Brexit panic: AstraZeneca plc (LON: AZN), Shire plc…

Read more »

Investing Articles

Whitbread plc, Shire plc and Marshalls plc beg your attention following the referendum sell-off

Quality firms Whitbread plc (LON: WTB), Shire plc (LON: SHP) and Marshalls plc (LON: MSLH) deserve a close look right…

Read more »

Investing Articles

3 Stocks That Could Surge In Q3! Randgold Resources Limited, GlaxoSmithKline plc and British American Tobacco plc

Royston Wild considers the share price prospects of Randgold Resources Limited (LON: RRS), GlaxoSmithKline plc (LON: GSK) and British American…

Read more »

Investing Articles

Will Indivior plc (+71%), Serco Group plc (+33%) & Indus Gas Limited (+105%) be among 2016’s big winners?

Can Indivior plc (LON: INDV), Serco Group plc (LON: SRP) & Indus Gas Limited (LON: INDI) keep on climbing?

Read more »

Investing Articles

Why GlaxoSmithKline plc looks set to be beaten by Inmarsat Plc

Inmarsat plc's (LON: ISAT) strong cash flow could help the firm beat GlaxoSmithKline plc (LON: GSK).

Read more »